Subodh Verma


Scientist, Keenan Research Centre for Biomedical Science


Please note: Dr. Verma will not take students in summer 2019.

Dr. Subodh Verma is a cardiac surgeon-scientist at St. Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis. He has been on the India Abroad Power List, recognized as one of Canada’s Top 40 under 40, and honoured with the Howard Morgan Award from the International Academy of Cardiovascular Sciences and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the Royal Society of Canada College of New Scholars, Artists and Scientists, and an inductee of the American Association of Thoracic Surgeons. Dr. Verma runs a practice that encompasses the entire spectrum of adult cardiac surgery (with a special interest in mitral valve repair and bicuspid aortopathy).

He is involved in several clinical trials and oversees a dynamic pre-clinical research laboratory that focuses on the roles of risk factors, inflammation and autophagy in cardiovascular health. His innovative research has culminated in nearly 300 peer-reviewed papers and two United States patents. Dr. Verma’s meta-analysis revealing that bypass surgery is superior to angioplasty in patients with diabetes has been used by the American College of Cardiology and the Canadian Cardiovascular Society (CCS) to shape the recommendations around the best clinical choice for revascularization procedures involving individuals with diabetes. He has contributed to the CCS guidelines for antiplatelet therapy, atrial fibrillation, dyslipidemia, peripheral arterial disease, and stable coronary artery disease; Canadian Cardiovascular Surgery Position Statement and Canadian Cardiometabolic Risk Position Paper. Dr. Verma spearheads the CARDIOLINK platform that will conduct clinical trials in atrial fibrillation, aneurysm and cerebral protection, diabetes and secondary prevention, valvular heart disease, and critical limb ischemia. He (co-)founded and (co-)chairs many regional and national educational initiatives that include the Landmark Lecture, State of the Heart Symposium, Toronto Acute Coronary Syndrome Summit, St. Michael’s Heart Valve Summit, Advances in Cardiology, Current Issues in Cardiology, and At the Heart of Diabetes programs.


Recent Publications

  1. Verma, S, Mazer, CD, Perkovic, V. Is it time to REWIND the cardiorenal clock in diabetes?. Lancet. 2019; :. doi: 10.1016/S0140-6736(19)31267-X. PubMed PMID:31189510 .
  2. Yanagawa, B, An, KR, Ouzounian, M, Gaudino, M, Puskas, JD, Asaoka, N et al.. Management of Less-Than-Severe Aortic Stenosis during Coronary Bypass: A Systematic Review and Meta-Analysis. Innovations (Phila). 2019; :1556984519849639. doi: 10.1177/1556984519849639. PubMed PMID:31185776 .
  3. Verma, S, Bhatt, DL. More CREDENCE for SGLT2 Inhibition. Circulation. 2019; :. doi: 10.1161/CIRCULATIONAHA.119.041181. PubMed PMID:31181959 .
  4. Salata, K, Hussain, MA, de Mestral, C, Greco, E, Aljabri, BA, Sabongui, S et al.. Trends in elective and ruptured abdominal aortic aneurysm repair by practice setting in Ontario, Canada, from 2003 to 2016: a population-based time-series analysis. CMAJ Open. ;7 (2):E379-E384. doi: 10.9778/cmajo.20180173. PubMed PMID:31147379 .
  5. Li, B, Khan, S, Salata, K, Hussain, MA, de Mestral, C, Greco, E et al.. A systematic review and meta-analysis of the long-term outcomes of endovascular versus open repair of abdominal aortic aneurysm. J. Vasc. Surg. 2019; :. doi: 10.1016/j.jvs.2019.01.076. PubMed PMID:31147117 .
  6. Cooper, S, Teoh, H, Campeau, MA, Verma, S, Leask, RL. Empagliflozin restores the integrity of the endothelial glycocalyx in vitro. Mol. Cell. Biochem. 2019; :. doi: 10.1007/s11010-019-03555-2. PubMed PMID:31127491 .
  7. Khan, S, Li, B, Salata, K, Aljabri, BA, Hussain, MA, Khan, M et al.. The Current Status of Lithoplasty in Vascular Calcifications: A Systematic Review. Surg Innov. 2019; :1553350619848557. doi: 10.1177/1553350619848557. PubMed PMID:31074330 .
  8. Cherney, DZI, Odutayo, A, Verma, S. A Big Win for Diabetic Kidney Disease: CREDENCE. Cell Metab. 2019;29 (5):1024-1027. doi: 10.1016/j.cmet.2019.04.011. PubMed PMID:31067448 .
  9. Terenzi, DC, Trac, JZ, Teoh, H, Gerstein, HC, Bhatt, DL, Al-Omran, M et al.. Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk. Trends Mol Med. 2019; :. doi: 10.1016/j.molmed.2019.03.006. PubMed PMID:31053416 .
  10. Deb, S, Singh, SK, de Souza, D, Chu, MWA, Whitlock, R, Meyer, SR et al.. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449). J Cardiothorac Surg. 2019;14 (1):85. doi: 10.1186/s13019-019-0887-x. PubMed PMID:31046806 PubMed Central PMC6498551.
Search PubMed

Affiliations & Other Activities

  • Staff Surgeon, Division of Cardiology , St. Michael’s Hospital
  • Professor, Department of Surgery and Pharmacology & Toxicology, University of Toronto